Merck in den Nachrichten
Spitzenwissenschaft rettet Leben
Tamtam hat 20 aktuelle Artikel über Merck gefunden.
- Better Dividend for Retirees: AbbVie vs. Merck
- Merck price target raised to $165 from $150 at JPMorgan
- Merck’s antibody impresses with ‘highly competitive’ data in chronic skin disease
- Merck business unit opens R&D facility in Sheboygan Falls
- Moderna, Merck Rally On Cancer Vaccine Promise. But Is The Multi-Billion-Dollar Hype Real?
- Moderna Soars On Cancer Vaccine. Is mRNA Ready For Prime Time?
- Merck’s anti-TL1A antibody secures a win in ph. 2 hidradenitis suppurativa trial
- Why Merck (MRK) Dipped More Than Broader Market Today
- Why Merck (MRK) Dipped More Than Broader Market Today
- Merck pulls antibiotic for multidrug-resistant infections from US market
- Merck, Daiichi Sankyo retract accelerated approval request for lung cancer ADC
- AstraZeneca, Merck, Novo deals inject fresh global momentum into Chinese biotech
- Merck, SciBrunch Launch Up-to-$2.13B Collaboration to Develop Preclinical KRAS-Inhibiting Molecular Glue
- Merck pulls antibiotic from US market
- Merck, Daiichi scrap FDA application for B7-H3 ADC in lung cancer
- Daiichi Sankyo, Merck withdraw bid for accelerated approval of I-DXd in small cell lung cancer
- Merck discontinues a crucial antibiotic despite concerns over superbug resistance
- Merck & Co (MRK) Has Billions in Revenue to Defend. Can its Pipeline Do the Job?
- Merck Pays $400M for Cancer Drug Prospect From China-Based SciBrunch
- Merck, Daiichi pull lung cancer filing after FDA pushback deals another blow to $4B deal
Von Tamtam gesammelte Artikel, die sich auf das Unternehmen beziehen, die neuesten zuerst. Jeder verlinkt auf seine Quelle.
Sie verkaufen an Unternehmen wie Merck?
Tamtam findet die Unternehmen, die zu Ihrem idealen Kunden passen, recherchiert jeden Account und sagt Ihnen, wen Sie wann kontaktieren sollten.
Ähnliche Unternehmen finden